Lopinavir Completed Phase N/A Trials for Novel Coronavirus Infectious Disease (COVID-19) / Kaletra / Hydroxychloroquine / Lopinavir/Ritonavir / Favipiravir Treatment

IndicationsStatusPurposePhase
CompletedTreatmentNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT04376814Favipiravir Plus Hydroxychloroquine and Lopinavir/Ritonavir Plus Hydroxychloroquine in COVID-19